4.6 Article

Liver and White/Brown Fat Dystrophy Associates with Gut Microbiota and Metabolomic Alterations in 3xTg Alzheimer's Disease Mouse Model

期刊

METABOLITES
卷 12, 期 4, 页码 -

出版社

MDPI
DOI: 10.3390/metabo12040278

关键词

Alzheimer's disease mouse model; liver inflammation; adipose tissues; gut microbiota; metabolome; PET-CT imaging

资金

  1. JPI-HDHL-INTIMIC Knowledge Platform of Food, Diet, Intestinal Microbiomics, and Human Health [KP-778, 23092/7303/19 MISVILUPPO]
  2. JPI-HDHL-INTIMIC Joint Transnational Research program [INTIMIC-085 GUTMOM, 946/2019]
  3. Fund for Scientific Research (FRS-FNRS, Belgium)
  4. Research Foundation-Flanders (FWO, Belgium)
  5. INSERM Institut National de la Sante et de la Recherche Medicale (France)
  6. Federal Ministry of Food and Agriculture (BMEL)
  7. Ministry of Education, University and Research (MIUR)
  8. Ministry of agricultural, food, and forestry policies (MiPAAF)
  9. National Institute of Health (ISS) on behalf of the Ministry of Health (Italy)
  10. National Institute of Health Carlos III (Spain)
  11. Netherlands Organisation for Health Research and Development (ZonMw, The Netherlands)
  12. Austrian Research Promotion Agency (FFG) on behalf of the Austrian Federal Ministry for Education, Science, and Research (BMBWF)
  13. Ministry of Science and Technology (Israel)
  14. Formas (Sweden)
  15. Ministry of Science and Innovation of Spain [ACPIN2017-117, PID2019-108973RB-C22]

向作者/读者索取更多资源

Metabolic impairments and alterations in liver and adipose depots were observed in subjects with Alzheimer's disease (AD), and the gut microbiota may play a modulating role. In a mouse model of AD, we investigated the changes in liver and white/brown adipose tissues and their associations with serum and gut metabolites and gut bacteria. The findings showed impaired lipid accumulation in liver and adipose tissues, along with disrupted gut microbiota profiles.
Metabolic impairments and liver and adipose depots alterations were reported in subjects with Alzheimer's disease (AD), highlighting the role of the liver-adipose-tissue-brain axis in AD pathophysiology. The gut microbiota might play a modulating role. We investigated the alterations to the liver and white/brown adipose tissues (W/BAT) and their relationships with serum and gut metabolites and gut bacteria in a 3xTg mouse model during AD onset (adulthood) and progression (aging) and the impact of high-fat diet (HFD) and intranasal insulin (INI). Glucose metabolism ((18)FDG-PET), tissue radiodensity (CT), liver and W/BAT histology, BAT-thermogenic markers were analyzed. 16S-RNA sequencing and mass-spectrometry were performed in adult (8 months) and aged (14 months) 3xTg-AD mice with a high-fat or control diet. Generalized and HFD resistant deficiency of lipid accumulation in both liver and W/BAT, hypermetabolism in WAT (adulthood) and BAT (aging), abnormal cytokine-hormone profiles, and liver inflammation were observed in 3xTg mice; INI could antagonize all these alterations. Specific gut microbiota-metabolome profiles correlated with a significant disruption of the gut-microbiota-liver-adipose axis in AD mice. In conclusion, fat dystrophy in liver and adipose depots contributes to AD progression, and associates with altered profiles of the gut microbiota, which candidates as an appealing early target for preventive intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据